Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 38th annual J.P. Morgan Healthcare Conference in San Francisco. Frank...
Bruker Corporation (Nasdaq: BRKR) today announced that it has completed certain debt financing actions intended to enhance its financial flexibility...
At the 2019 joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), Bruker (Nasdaq: BRKR)...
Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences: Stifel 2019 Healthcare Conference, New York, NY...
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of...
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2019. Third...
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2019 financial results on Thursday, October 31, 2019, after the market ...
Bruker (Nasdaq: BRKR) today announced the acquisition of the Magnettech EPR business from Freiberg Instruments GmbH, and the establishment of a...
Murdoch University and Bruker (Nasdaq: BRKR) today announced a strategic collaboration that will help transform the prevention and diagnosis of...
At the 18th Human Proteome Organization World Congress (www.hupo2019.org), Bruker (Nasdaq: BRKR) today announced the release of the diaPASEF...
At the 4th Annual European Forum on Nanoscale IR Spectroscopy, Bruker (Nasdaq: BRKR) today announced the release of the nanoIR3-s Broadband™, the...
t the 9th AFM BioMed Conference, Bruker Corporation (Nasdaq: BRKR) today announced the release of the NanoWizard® 4 XP extreme performance Bio-AFM...
At EUROISMAR 2019 (https://conference.euroismar2019.org), Bruker Corporation (Nasdaq: BRKR) today announced the world's first 1.2 GHz...
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2019. Second Quarter ...
Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2019 financial results on Thursday, August 1, 2019, after the market...
Bruker Corporation (Nasdaq: BRKR) has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as...
Bruker today announced that it has acquired PMOD Technologies LLC, a highly respected provider of research-use-only software for preclinical and...
At Metabolomics 2019 (metabolomics2019.org), Bruker highlights innovative mass spectrometry (MS) and Nuclear Magnetic Resonance (NMR) systems and...
At the ASM Microbe Conference 2019 (www.asm.org), Bruker launches the new MALDI Biotyper sirius system for all previously FDA-cleared, and for all...
Bruker Corporation (Nasdaq: BRKR) will host an Investor Day on June 20th, 2019, starting at 8:00 AM Eastern Time, at the Nasdaq MarketSite, 4 Times...
At the 67th American Society for Mass Spectrometry Conference (ASMS) being held June 2-6 in Atlanta, Bruker is announcing highly innovative new mass...
Bruker Corporation (Nasdaq: BRKR) announced today that it will participate in a fireside chat at the Jefferies 2019 Global Healthcare Conference in...
At the Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM), Bruker today announced an agreement to develop the...
Bruker Corporation (NASDAQ: BRKR) today announced that on May 9, 2019, its Board of Directors approved a new share repurchase authorization for the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.